Pharma fears “lack of focus” on no-deal Brexit preparations

supply. That is the view of Merck KGaA chief executive and President of European pharma's EFPIA, Stefan Oschmann, who says that the pharma industry has “been concerned by a certain ... EFPIA president Stefan Oschmann . He suggests in a blog post on

Industry aghast as EU Parliament backs biosimilar rule change

In an open letter to European institutions, the president of the EFPIA trade body, Merck KGaA chairman and CEO Stefan Oschmann (below), says the EP’s provisions “diverge significantly from the

Europe closer to biosimilar rule change, despite fierce resistance from pharma

Europe’s pharma industry body EFPIA says the changes send a signal that Europe is “weakening its commitment to IP incentives and innovation”. ... EFPIA says there are a handful of measures which would help limit the impact of the new rule:.

Industry pleads for compromise after Brexit defeat

The European Federation of Pharmaceutical Industries &Associations (EFPIA) thinks there are “very real, tangible and immediate threats to patient safety and public health in both the UK and across Europe” if ... EFPIA’s director general Nathalie

Beneluxa: the future of European market access?

Europe’s industry organisation EFPIA has thrown its weight behind the plans – believing that eliminating unnecessary duplication and creating a single clinical assessment methodology will in fact speed up access, rather

Brain power: fresh approaches to Alzheimer’s drug discovery

EPAD is co-funded by the Innovative Medicines Initiative (IMI) and Europe’s pharma industry organisation EFPIA, and 2019 will see the first patients being treated by this groundbreaking new alliance.

Uncertainty, austerity and Brexit

Life science companies, the ABPI and EFPIA have been clear that the UK and the EU need to provide businesses with ‘certainty’ so that they are able to create contingency plans

Brexit Means Brexit

These common-sense ambitions are broadly aligned with those of EFPIA and pharmaceutical companies across Europe.

A quest for innovative solutions

Increase returns. UCB is one of the partners in a consortium that includes other EFPIA companies, universities, research organisations, public bodies, non-profit groups and other third parties.

Healthcare systems

EFPIA appoints new director general

Joe Jiminez, president of EFPIA, said: “Nathalie has an excellent track record of leadership and engagement across the life science sector. ... We are confident she is the right person to lead EFPIA, working with stakeholders to address the challenges

IFPMA appoints director general

Thomas Cueni brings expertise from Interpharma and EFPIA. The International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) has selected Thomas Cueni as its new director general. ... Cueni also brings industry expertise from the

Bayer appoints president of Americas pharma business

He also brings branding and sales leadership experience from Novar tis and Eli Lilly, and recently served as chairman of European Federation of Pharmaceutical Industries and Associations (EFPIA), Japan.

Eric Cornut appointed EFPIA interim director general

Currently an independent consultant based in Basel, Switzerland, Cornut brings over 25 years of pharmaceutical management experience to the role, including five years as chairman of EFPIA's executive committee. ... work. “I am very pleased that Eric

EFPIA director general Richard Bergström resigns

Richard Bergström, director general of The European Federation of the Pharmaceutical Industries and Associates (EFPIA), has resigned his post. ... Described by the EFPIA's president Joe Jimenez as “the voice of the pharmaceutical industry in Europe

The changing face of medical communications over the past 15 years

Similarly, the launch of Disclosure UK’s searchable database, which went live in June 2016, is a helpful development for the UK (and Europe-wide through EFPIA), although details don’t

How Transparent Is Transparency?

So, what have we learnt? Is the  EFPIA  mission – to provide a greater understanding of the merits and ethics of the interactions between pharmaceutical companies and healthcare professionals (HCPs) – bearing any ... The EFPIA vision of enhanced

Brexit and Pharma: A match made in hell.

My husband and I woke up in the early hours of 24 June 2016 to the astonishing news that the UK had voted to leave the EU. It’s fair to say both of us shuddered and, while our perspectives were different, our concerns with regard to the complexity

Compliance Hub Ltd

Specialists in ABPI, ABHI and EFPIA codes of practice - provides training, audit and consultancy services.

Cameron Medical Communications Ltd

We specialise in: Marketing Codes of Practice, ABPI, EFPIA, IFPMA, Medical Information Systems and Services and Copyright.